Share This Article:

Pseudocholinesterase Deficiency: A Case Report and Literature Review

Full-Text HTML Download Download as PDF (Size:179KB) PP. 188-194
DOI: 10.4236/ojanes.2012.24043    5,939 Downloads   10,275 Views   Citations

ABSTRACT

A 72-year-old male underwent neck dissection and parotidectomy with facial nerve preservation. Endotracheal intubation was facilitated with succinylcholine. Prolonged muscle paralysis which was first detected after failure to stimulate the facial nerve with electrocautery, lasted five hours. Laboratory tests indicated pseudocholinesterase (PChE) deficiency. A thyroidectomy one month later was performed uneventfully using rocuronium as a muscle relaxant. Literature review revealed a total of 40 PChE deficiency cases being reported since 1956.

Cite this paper

P. Hackett and T. Sakai, "Pseudocholinesterase Deficiency: A Case Report and Literature Review," Open Journal of Anesthesiology, Vol. 2 No. 4, 2012, pp. 188-194. doi: 10.4236/ojanes.2012.24043.

References

[1] L. Putnam, “Pseudocholinesterase Deficiency: An Additional Preoperative Consideration in Outpatient Diagnostic Procedures,” Southern Medical Journal, Vol. 70, No. 7, 1977, pp. 831-833. doi:10.1097/00007611-197707000-00021
[2] B. Imerman and L. J. Caruso, “Prolonged Neuromuscular Block in a Patient Undergoing Renal Transplantation,” Journal of Clinical Anesthesia, Vol. 13, No. 7, 2001, pp. 540-544. doi:10.1016/S0952-8180(01)00321-X
[3] F. F. Foldes, L. Rendell-Baker and J. H. Birch, “Causes and Prevention of Prolonged Apnea with Succinylcholine,” Anesthesia and Analgesia, Vol. 35, No. 6, 1956, pp. 609-633. doi:10.1213/00000539-195611000-00005
[4] A. Maiorana, “Heterozygous Pseudocholinesterase Deficiency: A Case Report and Review of the Literature,” Journal of Oral Maxillofacial Surgery, Vol. 61, No. 7, 2003, 845-847. doi:10.1016/S0278-2391(03)00163-0
[5] C. Cerf, M. Mesguish, I. Gabriel, S. Amselem and P. Duvaldestin, “Screening Patient with Prolonged Neuromuscular Blockade after Succinylcholine and Mivacurium,” International Anesthesia Research Society, Vol. 94, No. 2, 2001, pp. 461-466.
[6] A. M. Karahasanoglu and P. Ozand, “Pseudocholinesterase: Two Cases of Pseudocholinesterase Deficiency,” The Turkish Journal of Pediatrics, Vol. 8, No. 1, 1966, pp. 10-19.
[7] A. J. Whyte and H. E. Wang, “Prehospital Airway Management Complicated by Reported Pseudocholinesterase Deficiency,” Prehospital Emergency Care, Vol. 11, No. 3, 2007, pp. 343-345. doi:10.1080/10903120701347984
[8] A. Niazi, I. E. Leonard and B. O’Kelly, “Prolonged Neuromuscular Blockade as a Result of Malnutrition-Induced Pseudocholinesterase Deficiency,” Journal of Clinical Anesthesia, Vol. 16, No. 1, 2004, pp. 40-42. doi:10.1016/j.jclinane.2003.02.010
[9] T. Archer and E. C. Janowsky, “Plasma Pseudocholinesterase Deficiency Associated with Diethylstilbestrol Therapy,” Anesthesia and Analgesia, Vol. 57, No. 6, 1978, pp. 726-729.
[10] V. Koseoglu, J. Chiang and K. W. Chan, “Acquired Pseudocholinesterase Deficiency after High-Dose Cyclophosphamide,” Bone Marrow Transplant, Vol. 24, No. 12, 1999, pp. 1367-1368. doi:10.1038/sj.bmt.1702097
[11] F. K. Soliday, Y. P. Conley and R. Henker, “Pseudocholinesterase Deficiency: A Comprehensive Review of Genetic, Acquired, and Drug Influences,” American Association of Nurse Anesthetists Journal, Vol. 78, No. 4, 2010, pp. 313-320.
[12] J. Williams, P. Rosenquist, L. Arias and W. V. McCall, “Pseudocholinesterase Deficiency and Electroconvulsive Therapy,” Journal of ECT, Vol. 23, No. 3, 2007, pp. 198200. doi:10.1097/YCT.0b013e318070c686
[13] K. Kendrick, “Prolonged Paralysis Related to Mivacurium: A Case Study,” Journal of Perianesthesia Nursing, Vol. 20, No. 1, 2005, pp. 7-12. doi:10.1016/j.jopan.2004.11.006
[14] C. A. Leadingham, “A Case of Pseudocholinesterase Deficiency in the PACU,” Journal of Perianesthesia Nursing, Vol. 22, No. 4, 2007, pp. 265-274. doi:10.1016/j.jopan.2007.05.005
[15] J. G. Ramirez, J. Sprung, M. T. Keegan and B. A. Hall, “Neostigmine-Induced Prolonged Neuromuscular Blockade in a Patient with Atypical Pseudocholinesterase,” Journal of Clinical Anesthesia, Vol. 17, No. 3, 2005, pp. 221-224. doi:10.1016/j.jclinane.2004.06.012
[16] W. E. Hodgkin, E. R. Giblett, H. Levine, W. Bauer and A. G. Motulsky, “Complete Pseudocholinesterase Deficiency: Genetic and Immunologic Characterization,” Journal of Clinical Investigation, Vol. 44, No. 3, 1965, pp. 486-493. doi:10.1172/JCI105162
[17] S. Lurie, O. Sadan, M. Glezerman and T. Ezri, “Pseudocholinesterase Deficiency Associated with HELLP Syndrome,” American Journal of Perinatology, Vol. 21, No. 6, 2004, pp. 315-317. doi:10.1055/s-2004-831881
[18] M. J. Lovely, S. K. Patteson, F. J. Beuerlein and J. T. Chesney, “Perioperative Blood Transfusion May Conceal Atypical Pseudocholinesterase,” Anesthesia and Analgesia, Vol. 70, No. 3, 1990, pp. 326-327. doi:10.1213/00000539-199003000-00017
[19] R. Gelo, A. Jurek-Gelo, R. Wardaszko and A. Kanski, “Congenital Pseudocholinesterase Deficiency,” Anesthesiology Intensive Therapy, Vol. 1, 2011, pp. 31-33.
[20] I. M. Reti, J. Torres, A. Morad and G. Javaram, “Pseudocholinesterase Deficiency in an ECT Patient: A Case Report,” Psychosomatics, Vol. 52, No. 4, 2011, pp. 392397. doi:10.1016/j.psym.2011.01.029
[21] C. Batistaki, K. Kesidis and S. Apostolaki, “Rocuronium Antagonized by Sugammadex for Series of Electroconvulsive Therapy (ECT) in a Patient with Pseudocholinesterase Deficiency,” Journal of ECT, Vol. 27, No. 1, 2011, pp. 47-48. doi:10.1097/YCT.0b013e318205e1d3
[22] J. Shiotsuka, M. Sanui and A. Lefor, “Safe Use of LanDiolol Hydrochloride in a Patient with Marked Pseudocholinesterase Deficiency,” Journal of Anesthesia, Vol. 24, No. 2, 2010, pp. 309-310. doi:10.1007/s00540-010-0889-2
[23] R. Somers, Y. Jacquemyn, L. SerMeus and M. Vercauteren, “Corrected Scoliosis, Cholinesterase Deficiency, and Cesarean Section: A Case Report,” Case Reports in Medecine, 2009, Article ID: 957479. doi:10.1155/2009/957479
[24] J. G. Augoustides, H. H. Hosalkar, J. P. O’Reardon, W. A. Kofke and C. J. Datto, “Customized Anesthetic Preservation of Ictal Threshold in Electroconvulsive Therapy: Role of Adjunctive Remifentanil with Etomidate,” Journal of ECT, Vol. 21, No. 2, 2005, pp. 128-131. doi:10.1097/01.yct.0000167463.71704.52
[25] F. G. Hicks, “ECT Modified by Atracurium,” Convulsive Therapy, Vol. 3, No. 1, 1987, pp. 54-59.
[26] B. R. Kuhnert, E. H Philipson, R. Pimental and P. M. Kuhnert, “A Prolonged Chloroprocaine Epidural Block in a Postpartum Patient with Abnormal Pseudocholinesterase,” Anesthesiology, Vol. 56, No. 6, 1982, pp. 477-478. doi:10.1097/00000542-198206000-00017
[27] M. Cherington and G. Lasater, “Prolonged Paralysis in Pseudocholinesterase Deficiency,” Archives of Neurology, Vol. 28, No. 4, 1973, pp. 274-275. doi:10.1001/archneur.1973.00490220082014
[28] D. P. Mullan and N. E. Williams, “Left-Sided Amoebic Liver Abscess with Pulmonary Involvement, Pericarditis, and Pseudocholinesterase Deficiency,” British Medical Journal, Vol. 1, 1965, pp. 235-236. doi:10.1136/bmj.1.5429.235
[29] L. Kaufman, H. Lehmann and E. Silk, “Suxamethonium Apnoea in an Infant: Expression of Familial Pseudocholinesterase Deficiency in Three Generations,” British Medical Journal, Vol. 1, 1960, pp. 166-167. doi:10.1136/bmj.1.5167.166
[30] E. Martinez-Amoros, E. Real, P. A. Barrado, M. Carulla, M. Urretavizcaya and N. Cardoner, “Optimizing Electroconvulsive Therapy in Non-Suspected Pseudocholinesterase Deficiency: Laryngeal Mask Use and Neuromuscular Selection,” Psychosomatics, Vol. 51, No. 6, 2010, pp. 537538.
[31] M. Hemadi, M. Purva and V. Traykova, “Unexpected Prolonged Neuromuscular Block after Mivacurium: A Case Report,” Medical Principles and Practice, Vol. 11, No. 1, 2002, pp. 50-52. doi:10.1159/000048662
[32] K. J. Grim, K. W. Arendt, A. K. Jacob, C. H. Rose and M. T. Keegan, “Urgent Cesarean Delivery and Prolonged Ventilatory Support in a Parturient with Fontan Circulation and Undiagnosed Pseudocholinesterase Deficiency,” International Journal of Obstetric Anesthesia, Vol. 10, No. 6, 2010, pp. 184-188.
[33] H. J. Southgate, S. K. Anderson, N. G. Lavies and M. J. Rymer, “Pseudocholinesterase Deficiency: A Dangerous, Unrecognized Complication of Ovarian Hyperstimulation Syndrome,” Annals of Clinical Biochemistry, Vol. 36, No. 2, 1999, pp. 256-258.
[34] V. Ho and H. Osiovich, “A Case of Pseudocholinesterase Deficiency in the Neonate,” American Journal of Perinatology, Vol. 16, No. 7, 1999, pp. 351-353. doi:10.1055/s-2007-993883
[35] J. Theodore, J. E. Millen, H. V. Murdaugh and E. D. Robin, “Prolonged Postoperative Apnea with Pseudocholinesterase Deficiency,” The American Review of Respiratory Disease, Vol. 96, No. 3, 1967, pp. 508-511.
[36] J. F. Glasgow and J. H. Elwood, “Pseudocholinesterase Deficiency,” Journal of the Irish Medical Association, Vol. 61, No. 374, 1968, pp. 268-272.
[37] J. S. Ruddell, “Apnea Due to Suxemathonium,” Lancet, Vol. 1, No. 7234, 1962, pp. 832-833. doi:10.1016/S0140-6736(62)91842-1
[38] P. S. Myles and R. N. Westhorpe, “A Patient with Sanfilippo Syndrome and Pseudocholinesterase Deficiency, Further Complicated by Post-Tonsillectomy Hemorrhage,” Anesthesia and Intensive Care, Vol. 17, No. 1, 1989, pp. 86-88.
[39] S. J. Chung and D. Andrews, “Prolonged Postoperative Succinylcholine-Induced Apnea with Pseudocholinesterase Deficiency,” Journal of Tennessee Medical Association, Vol. 75, No. 8, 1982, pp. 535-536.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.